Filtered by category: Performance Measurement Clear Filter

COPD Treatment Ratio - A Measure for Improving COPD Population Health

Chronic obstructive pulmonary disease (COPD) is a serious global health concern impacting millions of individuals. Despite being the third leading cause of mortality worldwide, COPD remains underdiagnosed and undertreated. Quality measures are a vital component of value-based payment models, but there are few COPD measures in current U.S. quality reporting programs, despite the established burden of COPD.

Read More

Piloting the PQA Specialty Pharmacy Turnaround Time Quality Measure

The use of specialty medicine has grown rapidly in recent decades, fueling parallel growth in the number of specialty pharmacies that serve patients who are prescribed specialty medications. Patients receiving specialty medications often have complex, high-cost treatment needs, necessitating close management from care teams, including specialty pharmacies. Specialty pharmacies dispense medications, for which timely initiation of therapy is a clinical priority to optimize outcomes 

Read More

Persistence to Basal Insulin Association With Improved Health Outcomes

Insulin persistence is associated with positive health and economic outcomes, according to a study conducted by researchers at the University of Mississippi, the Pharmacy Quality Alliance (PQA), and Ohio Northern University, the results of which were published in Clinical Diabetes in December of 2023. The study highlights the promising applicability of a method to measure insulin persistence at the population level. This same method is the foundation for PQA’s Persistence to Basal Insulin (PST-INS) health plan performance measure.

Read More

PQA Appoints New Members to Serve on MUP and QMEP in 2024

PQA has appointed individuals from member organizations to serve on the 2024 PQA Measure Update Panel (MUP) and Quality Metrics Expert Panel (QMEP). 

Read More

Public Comment Sought: Draft Call to Action to Advance MTM Quality Measurement

PQA is working with its members and the broader medication therapy management (MTM) community to build consensus on the research, measurement and strategies needed to evolve our national approach to evaluating MTM service quality. 

Read More

Diabetes Medications, Weight Loss Indications, and What It Means for Quality Measurement

Diabetes is a chronic health condition that affects how the body produces or uses insulin, the hormone that regulates blood sugar.1  In the US, 34.2 million adults have diabetes, and 1 in 5 are unaware of their diagnosis.2 Medication is a mainstay in diabetes treatment, and a wide variety of medication classes are used to manage the disease.  

Read More

Convening to Advance MTM Service Quality Measurement

Registration has opened forPQA Convenes: Advancing Medication Therapy Management Quality Measurement,” which will take place on Thursday, November 2 in Arlington, Va. This invite-only event will bring together PQA members and industry experts to discuss the state of medication therapy management (MTM) practice, implications of recent Centers for Medicare & Medicaid Services (CMS)proposals and opportunities to evolve MTM quality measurement. 

Read More

PQA Seeks Pharmacy and Payer Partners for Adult Immunization Pilots

The Pharmacy Quality Alliance (PQA) seeks interested pharmacy and payer partners to participate in proof-of-concept pilots to implement and test high priority immunization pharmacy measure concepts.

Read More

Aiming for the Next Generation of MTM Quality Measures

PQA has launched the PQA Quality Innovation and Research Initiative to Advance Medication Therapy Management Quality Measurement – a national initiative to advance medication therapy management (MTM) quality measurement and other strategies to evaluate MTM services.

Read More

PQA Appoints 16 Individuals to Specialty Pharmacy Prescription Abandonment Rate TEP

PQA has appointed 16 individuals from member organizations to serve on a technical expert panel (TEP) to review and provide input on draft specifications for the pharmacy measure concept, Specialty Pharmacy Prescription Abandonment Rate [Pharmacy] (SP-AR-PH).

Read More

PQA Appoints 19 Individuals to Health Equity TEP

PQA has appointed 19 individuals from member organizations to serve on a technical expert panel (TEP) to review and provide input on specific approaches to ensuring PQA’s measures support equitable health care.

Read More

PQA Sociodemographic Status Risk Adjustment FAQs

Health outcomes can be influenced by many factors other than the health care services received, including patient-related factors such as existing clinical conditions and sociodemographic status (SDS), which refers to a variety of socioeconomic (e.g., income, education, occupation) and demographic factors (e.g., age, race, ethnicity, primary language).  

Read More

PQA Measures in CMS Quality Programs

PQA uses a systematic, transparent, and consensus-based process to conceptualize, specify, test, and endorse quality measures. Following endorsement by PQA’s membership, PQA measures can be implemented into various quality programs, including those maintained by the Centers for Medicare & Medicaid Services (CMS). Many PQA measures are used in CMS Quality Programs to evaluate safe and appropriate medication use among beneficiaries.

Read More

PQA Appoints New Members to Serve on MUP and QMEP

PQA has appointed individuals from member organizations to serve on the 2023 PQA Measure Update Panel (MUP) and Quality Metrics Expert Panel (QMEP).

Read More

Measure Retirement Process With Member Input

PQA follows a systematic, transparent, and consensus-based process in the development and maintenance of measures. This process ensures that PQA measures are relevant and continue to support improvement in health care.

Read More

PQA is Soliciting Feedback on Health Plan PDC Composite Measure

The Pharmacy Quality Alliance (PQA) has developed a new health plan performance measure focused on medication adherence, Proportion of Days Covered Composite (PDC-CMP). PQA is actively soliciting feedback on this measure via a public comment period which opened on October 3 and will close on October 24, 2022. Stakeholders are invited to provide comments  

Read More

PQA Appoints 15 Individuals to Serve on COPD Treatment Ratio TEP

PQA has appointed 15 individuals from member organizations to serve on a technical expert panel (TEP) to review and provide input on draft specification for a health plan performance measure concept: COPD (chronic obstructive pulmonary disease) Treatment Ratio (CTR). 

Read More

PQA Developing Health Plan Measure for COPD Treatment Ratio

PQA, the Pharmacy Quality Alliance, has begun developing a health plan performance measure for chronic obstructive pulmonary disease (COPD). 

Read More

Measure Stewardship with Expert Input and Consensus-Based Process

PQA follows a systematic, transparent and consensus-based development process to ensure that measures are important, scientifically acceptable, feasible and usable. However, the measurement lifecycle does not end when a measure is endorsed.  

Read More

Understanding PQA Measures

Quality measures are standards for measuring the performance of health care providers to care for patients and populations. PQA develops and stewards measures focused on medication use. 

Read More